AAPS PharmSci 360

Event details

Website:
Location: Walter E. Washington Convention Center, 801 Mt Vernon Pl NW, Washington, DC 20001, United States, America
About
AAPS member leaders have redesigned the annual meeting to address user needs. Members told AAPS that they are now responsible for learning and understanding more about the cross-pollination of the biomolecular and chemical entities. AAPS has responded to this need by redesigning every aspect of the annual meeting, to create a more impactful format, PharmSci 360.This new meeting is designed to:

  • Increase collaboration between small molecule and biologics-focused scientists
  • Provide conference attendees a meaningful and engaging learning experience
  • Focus on new research and accomplish business objectives
  • Provide training on new hot topics
  • Take advantage of the great strength of the AAPS community: cross-discipline learning experiences

The Program
Every part of the new event is designed to build up scientific knowledge and collaboration. There will be sessions grouped into tracks and split into chemical and biomolecule areas.

Tracks
The scientific program will be grouped into five tracks:

  • Preclinical including Discovery
  • Bioanalytical
  • Clinical Pharmacology
  • Manufacturing & Bioprocessing
  • Formulation & Quality

Within each track, the program will offer parallel tracks covering the chemical entity and biomolecule areas, each offering scientific depth through symposia, keynote talks, and rapid-fire presentations.

Each of those tracks will be split into two disciplines, and attendees will be able to follow a thematic topic from end to end through the different tracks, to gain breadth in that area.

Rapid-fire Presentations
The final piece of the programming will be the rapid-fire presentations. These presentations will feature new scientific research never presented at other meetings. Scientists can expect novel, cutting-edge research—only available at PharmSci 360.

The Solution Center
The new Solution Center will feature both proven and experimental methods of learning and connecting, through exhibiting partner booths, Poster Forums, the Career Development Center, and our new Communities. The Solution Center features unique meeting spaces, including the central Hub, designed to encourage conversation and collaboration.
The Program Development Process
A new committee is being formed to develop programming, the 2018 PharmSci 360 Programming Committee. AAPS will announce details on this committee in November, at the 2017 Annual Meeting and Exposition in San Diego.The committee will identify potential critical track themes for 2018 based on:

  • Chemical questions and topics, focusing on top concerns for chemical scientists
  • Biomolecular science questions and topics, focusing on top concerns for biomolecular scientists

Timeline:

  • November 2017: Committee details will be announce in November at the Annual Meeting in San Diego.
  • February 2018: The committee will finalize the two hot tracks for 2018
  • March 2018: Once the tracks and the objectives for each track’s daily programming are determined, AAPS will issue a targeted call for symposia proposals
  • May 2018: Final selection of proposals will be announced. All proposals must follow the targeted call based on specific tracks
  • September 2018: The rapid-fire presentation schedule will be announced

 

BioAgilityxPRA HealthMilliporeSigma
Presentations

Press releases

BioAgilytix Announces Extensive Facilities Expansion Plan at Its USA Headquarters

BioAgilytix Remains Committed to Diversity as Global Growth Accelerates

Scientific Content

Making an Impact: Biomarkers Inform the Drug Development Process for Large and Small Molecule Drugs

Biologics Market Growth Demands Quality Science that Can Keep Pace

Proof of Concept to Solution: A Unique Approach to Anti-PEG Antibodies Assessment

We are hosting a charity event at our booth #503 to benefit Thrive DC. We are asking booth visitors to help us assemble kits for the homeless in the DC area.

Some information on Thrive DC:

At the Heart of a New Start

Thrive DC works to prevent and end homelessness in Washington, DC by providing vulnerable people with a wide range of services to help stabilize their lives. Founded in 1979 to serve dinner to homeless women, Thrive DC has grown to be a comprehensive, professionally staffed, bilingual organization serving more than 2,000 men, women, and children each year.

For more information, please click here.

Visit us at booth 2115

Meet with our team of experts at Booth 2115 to learn about our latest products and services, and our complete portfolio for all stages of the drug manufacturing process, from research to industrial-scale production and quality control.

Our newest technologies will improve productivity, lower risks, reduce costs and ensure safety. Together, we are advancing pharmaceutical production to accelerate development of therapeutic drug for patients in need.

Posters

A bead-based multiplex immunoassay for cancer autoantibody biomarker discovery

InnoPlex High throughput PCA based HOS confirmation for Novel therapeutic Mabs

Custom Milliplex assay solutions article

The Power of Single Molecule Counting:The Future of Immunoassays

We look forward to your participation in preparing for the new PharmSci 360.